Skip to main content

12 May 2026

Last updated: Tuesday 12 May 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The stakes for biopharma from German drug policy

Sunday 24 November 2013

Interviewee/Contributor

Matthias Heck

Organisation

German Pharmaceutical Industry Association

Organisations

Abivax SA
European Commission
Massachusetts General Hospital
Novartis
Lytix Biopharma AS
Simmons and Simmons LLP
German Pharmaceutical Industry Association
BC Platforms AG
Zelluna Immunotherapy AS
Poxel SA

Interviewees and Contributers

Eric Olson
Paul Kemp
Christopher Evans
Douglas Melton
Heather Graz
Tim Knotnerus
Richard Goodfellow
Désiré Collen
Willem de Laat
Jónas Einarsson

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec appoints COO and CCO

Thursday 23 April 2026

Immunic appoints CNS expert to board

Thursday 16 April 2026

CEPI appoints board members

Thursday 16 April 2026

New CEO at Orano Med

Thursday 16 April 2026

Aravax names two board members

Thursday 16 April 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form